外文期刊订阅>期刊> Expert Opinion on Therapeutic Targets

(被订阅24次)

  出版社: Informa Healthcare
  期刊类型: 月刊
  影响因子: 3.333
  ISSN: 1472-8222
  所在领域: 药物研发   
 
 

 

 

 

Expert Opinion on Therapeutic Targets is the prem...

展开

 

 

 

Expert Opinion on Therapeutic Targets is the premier journal dedicated to in-depth reports and reviews of the latest developments in the field of drug target discovery and validation. Expert Opinion on Therapeutic Targets is a peer-reviewed journal providing evaluated and expert reviews of recent research identifying novel molecular drug targets. The journal provides an essential link between basic research on biological pathways and interactions, and the development of the drugs of tomorrow.

收缩

 

Expert Opinion on Therapeutic Targets

中文名: 治疗靶标专家评论  缩写名: Expert Opin. Ther. Targets

收入刊期 2012年   2011年   2010年   2009年   2008年  

最新期2012年16-4s期内容

1 NF-kappa B as a target for pancreatic cancer therapy
2 The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
3 Integration of radioembolisation into multimodal treatment of liver-dominant metastatic colorectal cancer
4 The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
5 Current status of targeted therapies in advanced gastric cancer
6 The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer
7 Is there something other than imatinib mesilate in therapeutic options for GIST?
8 Oral tyrosine kinase inhibitors in the first-line treatment of advanced non-small cell lung cancer
9 Metastatic melanoma: the new era of targeted therapy
10 Combined modality treatments in pancreatic cancer
11 Poly (ADP-ribose) polymerase (PARP): rationale, preclinical and clinical evidences of its inhibition as breast cancer treatment
12 Therapy innovation for the treatment of pancreatic neuroendocrine tumors
13 Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines
14 Premetastatic niche: ready for new therapeutic interventions?
更多
本刊文章检索  
  文章名  
  作者  
  摘要